Pathology 1. Bai H, Gayyed MF,
Lam-Himlin DM, Klein AP, Nayar SK, Xu Y, Khan M, Argani P, Pan D, Anders
RA. Expression of Yes-associated protein modulates Survivin expression
in primary liver malignancies. Hum Pathol. 2012 Sep;43(9):1376-85. 2. Bai H, Zhang N, Xu Y, Chen Q, Khan M, Potter
JJ, Nayar SK, Cornish T, Alpini G, Bronk S, Pan D, Anders RA. Yes-associated
protein regulates the hepatic response after bile duct ligation. Hepatology.
2012 Sep;56(3):1097-107. 3. Caturegli P, De Remigis A, Ferlito M, Landek-Salgado
MA, Iwama S, Tzou SC, Ladenson PW. Anatabine ameliorates experimental
autoimmune thyroiditis. Endocrinology. 2012 Sep;153(9):4580-7. 4. Chang CL, Hsu YT, Wu CC, Yang YC, Wang C, Wu
TC, Hung CF. Immune mechanism of the antitumor effects generated by
bortezomib. J Immunol. 2012 Sep 15;189(6):3209-20. 5. Chaux A, Brimo F, Gonzalez-Roibon N, Shah S,
Schultz L, Rizk JM, Argani P, Hicks J, Netto GJ. Immunohistochemical
evidence of dysregulation of the Mammalian target of rapamycin pathway
in primary and metastatic pheochromocytomas. Urology. 2012 Sep;80(3):736.e7-736.e12. 6. Descipio C, Conlin L, Rosenfeld J, Tepperberg
J, Pasion R, Patel A, McDonald MT, Aradhya S, Ho D, Goldstein J, McGuire
M, Mulchandani S, Medne L, Rupps R, Serrano AH, Thorland EC, Tsai AC,
Hilhorst-Hofstee Y, Ruivenkamp CA, Van Esch H, Addor MC, Martinet D,
Mason TB, Clark D, Spinner NB, Krantz ID. Subtelomeric deletion of chromosome
10p15.3: Clinical findings and molecular cytogenetic characterization.
Am J Med Genet A. 2012 Sep;158A(9):2152-61. 7. Fu B, Yachida S, Morgan R, Zhong Y, Montgomery
EA, Iacobuzio-Donahue CA. Clinicopathologic and genetic characterization
of traditional serrated adenomas of the colon. Am J Clin Pathol. 2012
Sep;138(3):356-66. 8. Guo Z, Rudow G, Pletnikova O, Codispoti KE,
Orr BA, Crain BJ, Duan W, Margolis RL, Rosenblatt A, Ross CA, Troncoso
JC. Striatal neuronal loss correlates with clinical motor impairment
in Huntington's disease. Mov Disord. 2012 Sep 15;27(11):1379-86. 9. Iacobuzio-Donahue CA. Personalized medicine
in pancreatic cancer: prognosis and potential implications for therapy.
J Gastrointest Surg. 2012 Sep;16(9):1651-2. 10. Kuhn E, Kurman RJ, Sehdev AS, Shih IeM. Ki-67
labeling index as an adjunct in the diagnosis of serous tubal intraepithelial
carcinoma. Int J Gynecol Pathol. 2012 Sep;31(5):416-22. 11. Landek-Salgado MA, Leporati P, Lupi I, Geis
A, Caturegli P. Growth hormone and proopiomelanocortin are targeted
by autoantibodies in a patient with biopsy-proven IgG4-related hypophysitis.
Pituitary. 2012 Sep;15(3):412-9. 12. Matthaei H, Wylie D, Lloyd MB, Dal Molin M,
Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss
BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra A. miRNA biomarkers
in cyst fluid augment the diagnosis and management of pancreatic cysts.
Clin Cancer Res. 2012 Sep 1;18(17):4713-24. 13. Rodriguez FJ, Ligon AH, Horkayne-Szakaly I,
Rushing EJ, Ligon KL, Vena N, Garcia DI, Cameron JD, Eberhart CG. BRAF
Duplications and MAPK pathway activation are frequent in gliomas of
the optic nerve proper. J Neuropathol Exp Neurol 2012 Sep;71(9):789-94. 14. Ross HM, Kryvenko O, Cowan J, Simko JP, Wheeler
TM, Epstein JI. Do adenocarcinomas of the prostate with Gleason score
(GS) <6 have the potential to metastasize to lymph nodes? Am J Surg
Pathol. 2012 Sep;36(9):1346-52. 15. Yu J, Walter K, Omura N, Hong S-M, Young
A, Li A, Vincent A, Goggins M. Unlike pancreatic cancer cells pancreatic
cancer associated fibroblasts display minimal gene induction after 5-aza-2?-deoxycytidine.
PLoS One. 2012 Sept;7(9):e43456.
|
|
||||||||
|
|
|
|
|
JHM Appointments | Employment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM |
|
|